Session 4: Company Analysis Workshop with Randall Reade of Washington, DC ArchAngels
What do investors look for when they see a pitch? And how do they analyze a company to determine if it is investment worthy? Join us for a special workshop that will teach you the major elements that investors ask themselves about a company. We will have two real companies seeking funding that will pitch, and the audience will apply what they learned and determine whether the companies are investment worthy.
Bridge Therapeutics, Inc. (“Treating Pain without Addiction”) is a quick-to-sales biopharma company disrupting $35B+ markets and saving thousands of lives. By improving on generic drugs, Bridge has none of the discovery risk and little of the approval risk that’s typical of pharma startups. By protecting its, Bridge can establish a franchise which addresses root causes of the Opioid Crisis, namely the needs for strong, yet safe pain relief and easy to administer addiction therapy. Proof of concept is demonstrated by three dozen pain and addiction specialists becoming our shareholders, while Bridge’s management team is relevant, capable and experienced, guiding it to become a multi-billion-dollar company.
Social Currant is a platform that matches brands with influencers on TikTok to increase sales and awareness. Started less than two years ago, Social Currant has successfully led over a dozen businesses to greater visibility and successful sales through their partnerships with influencers.
Executive Vice President, Washington DC ArchAngels
Randall Reade is the co-founder of the Washington DC ArchAngels, an angel investment group that finds, vets, and presents early stage companies to hundreds of investors. Founded in 2011, The ArchAngels has presented over 800 companies from clean tech, biotech, medical devices, AI and blockchain, energy, apps, games, and even cookies. Read full profile…
CEO, Social Currant
Ashwath Narayanan is the founder and CEO of Social Currant. He is a recent graduate of The George Washington University where he majored in journalism and political science. Previously, he was a project manager for Community Engagement Consulting and Director of Communications for March for Our Lives. Read full profile…
President, Bridge Therapeutics
Tim Peara, MBA, President brings to Bridge deep experience in business development and finance, building departments for large companies as well as developing projects and small technology companies, both in the USA and abroad. For 20 years Tim has developed technology start-ups (Greenfuel Technologies) and energy projects (Koch, GE) preceded by 14 years on Wall Street as an investment strategist (Prudential, Lehman). He earned a BA from Wesleyan University, Connecticut, an MBA from the University of Chicago’s Booth School of Business. Read full profile…